| # | Drug | Count |
|---|---|---|
| 0 | FUROSEMIDE | 25 |
| 1 | PREDNISONE | 21 |
| 2 | FLUCONAZOLE | 18 |
| 3 | METHYLPREDNISOLONE | 17 |
| 4 | ASPIRIN | 16 |
| 5 | ASPIRIN 325 MG | 15 |
| 6 | ASPIRIN 81 MG | 15 |
| 7 | ACETAMINOPHEN | 14 |
| 8 | LISINOPRIL | 13 |
| 9 | OMEPRAZOLE MAGNESIUM | 13 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PENCICLOVIR | 2 | 0.0055 |
| 1 | FERROUS ASPARTO GLYCINATE, IRON, ASCORBIC ACID, FOLIC ACID, CYANOCOBALAMIN, ZINC, AND SUCCINIC ACID | 3 | 0.0049 |
| 2 | PENTOSTATIN | 1 | 0.0010 |
| 3 | ALMOTRIPTAN | 1 | 0.0009 |
| 4 | NICARDIPINE HYDROCHLORIDE | 2 | 0.0009 |
| 5 | CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE | 2 | 0.0008 |
| 6 | SODIUM CHLORIDE 0.65% | 1 | 0.0007 |
| 7 | VANCOMYCIN HYDROCHLORIDE | 5 | 0.0006 |
| 8 | OFLOXACIN OTIC SOLUTION | 4 | 0.0006 |
| 9 | OFLOXACIN OPHTHALMIC SOLUTION USP, 0.3% | 4 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 40 |
| 1 | Loop Diuretic [EPC] | 28 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 27 |
| 3 | Azole Antifungal [EPC] | 20 |
| 4 | Proton Pump Inhibitor [EPC] | 19 |
| 5 | Benzodiazepine [EPC] | 16 |
| 6 | Platelet Aggregation Inhibitor [EPC] | 16 |
| 7 | Osmotic Laxative [EPC] | 15 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 12 |
| 9 | CD20-directed Cytolytic Antibody [EPC] | 11 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Quinolone Antimicrobial [EPC] | 4 | 0.0004 |
| 1 | Antimetabolite Immunosuppressant [EPC] | 7 | 0.0003 |
| 2 | Calcitonin [EPC] | 1 | 0.0003 |
| 3 | Echinocandin Antifungal [EPC] | 2 | 0.0002 |
| 4 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 2 | 0.0002 |
| 5 | CD52-directed Cytolytic Antibody [EPC] | 4 | 0.0002 |
| 6 | Polyene Antifungal [EPC] | 8 | 0.0002 |
| 7 | Vitamin D3 Analog [EPC] | 4 | 0.0002 |
| 8 | Autologous Cellular Immunotherapy [EPC] | 1 | 0.0002 |
| 9 | Provitamin D2 Compound [EPC] | 5 | 0.0002 |